ALK-Abello: New Tablet-Based Immunotherapy for Grass Allergy Approved.
PR Newswire Europe, March, 2006
HEyRSHOLM, Denmark, March 16 /PRNewswire/ --
- The Swedish Medical Products Agency has Approved ALK-Abello's Tablet-Based Immunotherapy, GRAZAX(R), for the Treatment of Grass Pollen Allergy. ALK-Abello will now Submit Applications for GRAZAX(R) in Other European Countries Using the Mutual Recognition Procedure
ALK-Abello's tablet-based immunotherapy, GRAZAX(R), has been approved by the Swedish Medical Products Agency for the treatment of grass pollen allergy.
ALK-Abello will now submit further applications in other European countries via the Mutual Recognition Procedure. ALK-Abello still expects GRAZAX(R) to be launched in the first European markets by the end of 2006.
"We are delighted with the Swedish regulatory decision. For...
Most Recent Business Articles
- Your feedback
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- The CLNC® mentors held the key to my first case and to my CLNC® success
- Atlanta CLNC® 6-day certification seminar photo gallery—plus sign up today for spring 2009 to save $100.00
- Announcing the 2009 NACLNC® conference keynote speaker, Stedman Graham: move like a maverick for breakaway CLNC® success at the 2009 NACLNC® conference
Most Recent Business Publications
Most Popular Business Articles
- Using object-oriented analysis and design over traditional structured analysis and design
- Big Fish Games Migrates Upstream to Fisher Plaza; High Growth Online Gaming Firm Vaults Fisher Plaza Occupancy Rate Above 90%
- Top of the line: some of the world's most well-respected doctors practice in South Florida. A guide to choosing the best physician specialists - Top Doctors in South Florida
- BEHR Paints Introduces a Colorful New Way to Paint and Prime All in One with BEHR Premium Plus Ultra™ Interior
- Sand filter basics: high-rate sand filters can be confusing for those new to the business. Understanding valve modes is the key
Sponsored by Merrill Lynch